Menü
Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

Erstellt von HC Wainwright 

Vivani Medical Inc. diskutieren

Vivani Medical Inc.

WKN: A3DTRX / Symbol: VANI / Name: Vivani Medical / Aktie / Ausrüstung & Versorgung / Small Cap /

1,17 €
4,46 %

Einschätzung Buy
Rendite (%) 19,44 %
Kursziel 2,78
Veränderung
Endet am 07.11.25

Vivani Medical, Inc. (NASDAQ: VANI) is now covered by analysts at HC Wainwright. They set a "buy" rating and a $3.00 price target on the stock.
Ratings data for VANI provided by MarketBeat

Einschätzung Buy
Rendite (%) 23,81 %
Kursziel 3,67
Veränderung
Endet am 13.03.26

Vivani Medical, Inc. (NASDAQ: VANI) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $4.00 price target on the stock.
Ratings data for VANI provided by MarketBeat

Einschätzung Buy
Rendite (%) 10,53 %
Kursziel 3,71
Veränderung
Endet am 26.03.26

Vivani Medical, Inc. (NASDAQ: VANI) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $4.00 price target on the stock.
Ratings data for VANI provided by MarketBeat

Einschätzung Buy
Rendite (%) 32,08 %
Kursziel 3,61
Veränderung
Endet am 04.04.26

Vivani Medical, Inc. (NASDAQ: VANI) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $4.00 price target on the stock.
Ratings data for VANI provided by MarketBeat

Einschätzung Buy
Rendite (%) 32,20 %
Kursziel 3,53
Veränderung
Endet am 16.04.26

Vivani Medical, Inc. (NASDAQ: VANI) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $4.00 price target on the stock.
Ratings data for VANI provided by MarketBeat

Einschätzung Buy
Rendite (%) 26,49 %
Kursziel 3,58
Veränderung
Endet am 19.05.26

Vivani Medical, Inc. (NASDAQ: VANI) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $4.00 price target on the stock.
Ratings data for VANI provided by MarketBeat

Einschätzung Buy
Rendite (%) 17,77 %
Kursziel 3,42
Veränderung
Endet am 02.09.26

Vivani Medical (NASDAQ:VANI) had its "buy" rating reaffirmed by analysts at HC Wainwright. They now have a $4.00 price target on the stock.
Ratings data for VANI provided by MarketBeat